ATE378404T1 - Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon - Google Patents
Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davonInfo
- Publication number
- ATE378404T1 ATE378404T1 AT02762445T AT02762445T ATE378404T1 AT E378404 T1 ATE378404 T1 AT E378404T1 AT 02762445 T AT02762445 T AT 02762445T AT 02762445 T AT02762445 T AT 02762445T AT E378404 T1 ATE378404 T1 AT E378404T1
- Authority
- AT
- Austria
- Prior art keywords
- oxidative stress
- kit
- implementing
- same
- risk factor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analyzing Materials Using Thermal Means (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BE2001/0545A BE1014949A3 (fr) | 2001-08-14 | 2001-08-14 | Procede de detection de stress oxydant et trousse pour sa mise en oeuvre. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE378404T1 true ATE378404T1 (de) | 2007-11-15 |
Family
ID=3897081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02762445T ATE378404T1 (de) | 2001-08-14 | 2002-08-13 | Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7288374B2 (de) |
| EP (1) | EP1423518B1 (de) |
| AT (1) | ATE378404T1 (de) |
| BE (1) | BE1014949A3 (de) |
| DE (1) | DE60223561T2 (de) |
| ES (1) | ES2296987T3 (de) |
| WO (1) | WO2003016527A2 (de) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7569342B2 (en) | 1997-12-10 | 2009-08-04 | Sierra Molecular Corp. | Removal of molecular assay interferences |
| GB0225885D0 (en) * | 2002-11-06 | 2002-12-11 | Isis Innovation | Quantifying exposure to stress |
| WO2004046729A2 (en) * | 2002-11-21 | 2004-06-03 | The University Of Leicester | Bodily fluid markers of tissue hypoxia |
| US20050065184A1 (en) * | 2003-08-29 | 2005-03-24 | Aaipharma Inc. | Method of reducing the risk of oxidative stress |
| GB0409153D0 (en) * | 2004-04-23 | 2004-05-26 | Randox Lab Ltd | Method of diagnosis |
| ES2315034B1 (es) * | 2004-07-02 | 2009-12-30 | Laboratorios Indas, S.A. | Proteina de choque termico 27 (hsp-27) como marcador de enfermedad cardiovascular. |
| EP2392674A3 (de) * | 2005-04-29 | 2012-03-07 | The University of Tennessee Research Foundation | Zellulärer Biomarker-Antioxidationsmitteltest und Verwendungen dafür |
| FR2894030B1 (fr) * | 2005-11-30 | 2008-07-04 | Michel Brack | Procede de determination d'un score representatif du stress oxydatif d'un patient, sur une echelle de 0 a 10 |
| EP2024517A2 (de) * | 2006-05-31 | 2009-02-18 | Health Research, Inc. | Verfahren zur vorhersage der empfänglichkeit für eine strahlungspneumonitis |
| WO2008019060A2 (en) * | 2006-08-03 | 2008-02-14 | U.S. Department Of Veterans Affairs Office Of General Counsel-Psg Iv (024) | Method for predicting onset/risk of atrial fibrillation (af) |
| FR2923609A1 (fr) | 2007-11-13 | 2009-05-15 | Thierry Patrice | Test pour la mesure de la resistance au stress oxydant et ses applications |
| AU2008326426A1 (en) * | 2007-11-19 | 2009-05-28 | Bionovo, Inc. | Methods of detecting and treatment of cancers using scuttelaria barbata extract |
| WO2012094580A2 (en) * | 2011-01-07 | 2012-07-12 | High Point Pharmaceuticals, Llc | Compounds that modulate oxidative stress |
| WO2012162260A2 (en) | 2011-05-21 | 2012-11-29 | Kdt, Llc. | Transgenic biosensors |
| US20140248293A1 (en) | 2011-09-08 | 2014-09-04 | Yeda Research And Development Co., Ltd | Novel risk biomarkers for lung cancer |
| RU2534821C2 (ru) * | 2012-05-18 | 2014-12-10 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" | Способ диагностики окислительного стресса измерением экспрессии кислородчувствительных генов (варианты) |
| AU2013359040A1 (en) | 2012-12-14 | 2015-07-02 | The Procter & Gamble Company | Fragrance materials |
| WO2014100361A1 (en) * | 2012-12-19 | 2014-06-26 | The Johns Hopkins University | Protection from oxidative damage by gene transfer by glutamate cysteine ligase and glutathione synthase |
| EP3287783B1 (de) * | 2013-03-15 | 2020-02-26 | The Procter & Gamble Company | Nicht-invasives verfahren zur diagnose von kopfschuppen durch messen von oxidierten lipiden in hautproben |
| RU2540500C2 (ru) * | 2013-05-07 | 2015-02-10 | Федеральное государственное бюджетное учреждение "Научно-исследовательский институт кардиологии" Сибирского отделения Российской академии медицинских наук | Способ прогнозирования ранней стадии апоптоза |
| RU2545900C2 (ru) * | 2013-05-07 | 2015-04-10 | Федеральное государственное бюджетное учреждение "Научно-исследовательский институт кардиологии" Сибирского отделения Российской академии медицинских наук | Способ диагностики апоптоза лимфоцитов |
| US9995758B1 (en) * | 2014-10-31 | 2018-06-12 | Western Autotroph Company LLC | Methods and systems for controlling oxidative stress in humans and animals |
| WO2016073931A1 (en) | 2014-11-07 | 2016-05-12 | The Johns Hopkins University | Treatment of retinitis pigmentosa with n-acetylcysteine amide |
| US11268964B2 (en) | 2014-11-11 | 2022-03-08 | The Johns Hopkins University | Biomarkers useful in the treatment of subjects having diseases of the eye |
| WO2017210360A1 (en) | 2016-05-31 | 2017-12-07 | Cardiovax, Llc | Methods for diagnosing and treating systemic lupus erythematosus |
| US10858422B2 (en) | 2016-05-31 | 2020-12-08 | Abcentra, Llc | Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody |
| US11548851B2 (en) | 2017-09-20 | 2023-01-10 | Nacuity Pharmaceuticals, Inc. | Method for preparation of n-acetyl cysteine amide and derivatives thereof |
| EP3684756A4 (de) | 2017-09-20 | 2020-10-28 | NaCuity Pharmaceuticals, Inc. | Verfahren zur herstellung von n-acetylcysteinamid und derivaten davon |
| US11091433B2 (en) | 2017-09-20 | 2021-08-17 | Nacuity Pharmaceutials, Inc. | Method for preparation of N-acetyl cysteine amide and derivatives thereof |
| US20190135741A1 (en) | 2017-11-09 | 2019-05-09 | Nacuity Pharmaceuticals, Inc. | Methods of Making Deuterium-Enriched N-acetylcysteine Amide (D-NACA) and (2R, 2R')-3,3'-Disulfanediyl BIS(2-Acetamidopropanamide) (DINACA) and Using D-NACA and DINACA to Treat Diseases Involving Oxidative Stress |
| CN109797133A (zh) * | 2019-01-09 | 2019-05-24 | 珠海金肽生物科技有限公司 | 多潜能细胞培养组合物及制备方法和应用 |
| JP7631200B2 (ja) | 2019-01-11 | 2025-02-18 | ナキュイティ ファーマシューティカルズ， インク． | 放射線皮膚炎の予防及び治療、並びに皮膚ライトニング、皮膚ホワイトニング、並びに皮膚改善のためのｎ－アセチルシステインアミド（ｎａｃａ）及び（２ｒ，２ｒ’）－３，３’－ジスルファンジイルビス（２－アセトアミドプロパンアミド）（ｄｉｎａｃａ） |
| WO2020146660A1 (en) | 2019-01-11 | 2020-07-16 | Nacuity Pharmaceuticals, Inc. | N-acetylcysteine amide (naca) and (2r,2r')-3-3'-disulfanediyl bis (2-acetamidopropanamide) (dinaca) for prevention and treatment of radiation pneumonitis and treatment of pulmonary function in cystic fibrosis |
| AU2020206139A1 (en) | 2019-01-11 | 2021-07-29 | Nacuity Pharmaceuticals, Inc. | Treatment of age-related macular degeneration, glaucoma, and diabetic retinopathy with N-acetylicysteine amide (NACA) or 2R,2R')-3-3'-disulfanediyl bis (2-acetamidopropanamide) (diNACA) |
| CN112684020B (zh) * | 2020-12-01 | 2023-12-29 | 哈尔滨医科大学 | 一种用于评价个体锌营养状态的生物标志物及其应用 |
| DE102023124443A1 (de) | 2023-09-11 | 2025-03-27 | Albert-Ludwigs-Universität Freiburg, Körperschaft des öffentlichen Rechts | Vorrichtung zur Modifikation von Blut |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2056790T3 (es) * | 1986-01-17 | 1994-10-16 | Preventive Medicine Inst | Ensayo para determinar la predisposicion o susceptibilidad a enfermedades asociadas con dna. |
| WO1998021321A1 (en) * | 1996-11-12 | 1998-05-22 | Qbi Enterprises Ltd. | Method for identifying translationally regulated genes |
| EP0988398A4 (de) * | 1997-05-21 | 2005-05-18 | Clontech Lab Inc | Nukleinsäure-arrays |
| WO1999058718A1 (en) * | 1998-05-11 | 1999-11-18 | Quark Biotech Inc. | Method for identifying genes |
| AU4004699A (en) * | 1998-05-15 | 1999-12-06 | Quark Biotech, Inc. | Mechanical stress induced genes, expression products therefrom, and uses thereof |
| WO1999063341A2 (en) * | 1998-05-29 | 1999-12-09 | Nikken Foods Co., Ltd. | Use of oxidative stress diagnostic plot as a health indicator for assessing oxidative stress and its control in humans |
| EP1105532A1 (de) * | 1998-08-14 | 2001-06-13 | The Trustees Of The University Of Pennsylvania | Zusammensetzungen, kits, sowie verfahren zur hydrodynamischen stress-gekoppelten regulation der genexpression |
| WO2000065095A2 (en) * | 1999-04-23 | 2000-11-02 | Clontech Laboratories, Inc. | Methods and compositions for performing array based hybridization assays |
| US6607885B1 (en) * | 1999-10-15 | 2003-08-19 | E. I. Du Pont De Nemours And Company | Method for high-density microarray medicated gene expression profiling |
| AU1443001A (en) * | 1999-10-29 | 2001-05-14 | Cleveland Clinic Foundation, The | Method and apparatus for predicting male infertility |
| AU2872501A (en) * | 1999-12-21 | 2001-07-03 | Eirx Therapeutics Limited | Screening method |
| US6541265B2 (en) * | 2001-05-09 | 2003-04-01 | University Of Florida | Method and system to test a substance for inflammatory or oxidant properties |
| WO2003064994A2 (en) * | 2002-01-29 | 2003-08-07 | Talton James D | Methods of collecting and analyzing human breath |
-
2001
- 2001-08-14 BE BE2001/0545A patent/BE1014949A3/fr not_active IP Right Cessation
-
2002
- 2002-08-13 WO PCT/EP2002/009079 patent/WO2003016527A2/en not_active Ceased
- 2002-08-13 ES ES02762445T patent/ES2296987T3/es not_active Expired - Lifetime
- 2002-08-13 AT AT02762445T patent/ATE378404T1/de not_active IP Right Cessation
- 2002-08-13 EP EP02762445A patent/EP1423518B1/de not_active Expired - Lifetime
- 2002-08-13 US US10/487,091 patent/US7288374B2/en not_active Expired - Fee Related
- 2002-08-13 DE DE60223561T patent/DE60223561T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2296987T3 (es) | 2008-05-01 |
| DE60223561T2 (de) | 2008-05-29 |
| WO2003016527A3 (en) | 2003-12-31 |
| US7288374B2 (en) | 2007-10-30 |
| US20050112572A1 (en) | 2005-05-26 |
| EP1423518B1 (de) | 2007-11-14 |
| WO2003016527A2 (en) | 2003-02-27 |
| EP1423518A2 (de) | 2004-06-02 |
| DE60223561D1 (de) | 2007-12-27 |
| BE1014949A3 (fr) | 2004-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE378404T1 (de) | Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon | |
| WO2004055519A3 (en) | Specific markers for pancreatic cancer | |
| DE602005013670D1 (de) | Zusammensetzungen und verfahren zur quantifizierung von serumglykoproteinen | |
| ATE232559T1 (de) | Verfahren zur signalverstärkung | |
| DE60115314D1 (de) | Verfahren für die Auswertung von Bildern zur Defekterkennung | |
| DE60216389D1 (de) | Verfahren zur zerstörungsfreien Prüfung | |
| ATE540319T1 (de) | Verfahren für die bestimmung von fk506 | |
| DE69836888D1 (de) | Verfahren für Fluoreszenzerkennungstest | |
| DE59912512D1 (de) | Messanordnung zur Erfassung von Dimensionen von Prüflingen, vorzugsweise von Hohlkörpern, insbesondere von Bohrungen in Werkstücken, sowie Verfahren zur Messung solcher Dimensionen | |
| DE60305044D1 (de) | Verfahren und vorrichtung zur bestimmung von bor bei der röntgenfluoreszenz-spektroskopie | |
| DE69937835D1 (de) | Antikörper für apoptosemarker und anwendungsverfahren | |
| ATE476525T1 (de) | Verfahren zum nachweis von mit endometrialer krankheit oder phase assoziierten markern | |
| ATE408829T1 (de) | Verfahren und assaykits zum nachweis mononuklearer zellphänotypen | |
| DK1604203T3 (da) | Fremgangsmåde til direkte bestemmelse af individuelle methotrexatmeta-bolitter | |
| DE60021369D1 (de) | Verfahren zur abschätzung eines magengeschwür-risikos | |
| DE50203510D1 (de) | Verfahren zur erkennung und identifizierung von objekten | |
| DE60325382D1 (de) | Verfahren zur diagnose von gebärmutterhalskrebs | |
| ATE347105T1 (de) | Verfahren, assay und kit zur quantifizierung von hiv-proteasehemmer | |
| DE602004030041D1 (de) | Verfahren und zusammensetzungen zur identifikation von rna-bindenden proteinen | |
| ATE412182T1 (de) | Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome | |
| FI20040255A7 (fi) | Menetelmä pre-eklampsian riskin havaitsemiseksi | |
| DE60228952D1 (de) | Nachweis von Legionella durch ein PCR und FRET verwendendes Verfahren | |
| ATE288587T1 (de) | Verfahren zur bestimmung der lipid-aufnahme | |
| ATE408832T1 (de) | Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper | |
| DE602004011228D1 (de) | Verfahren und zusammensetzungen zur bestimmung glycierter proteine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |